Clinical Trial Update: Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders. [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the long-term safety and tolerability of pregabalin in adults with anxiety disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer | Conditions: Anxiety Neuroses | Phase 3 | Status: COMPLETED